Myelofibrosis, Post ET
3 clinical trials · Condition
◉ Watch Myelofibrosis, Post ET
| Record | Firm | Date |
|---|---|---|
| Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis (NCT03402399) | Assaf-Harofeh Medical Center | 2017-12-10 |
Track Myelofibrosis, Post ET automatically
Every clearance here is in the API, with alerts when new ones post.